Investor Adage Capital Management, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Adage Capital Management, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2026-05-13 13G XCBE / X3 Acquisition Corp. Ltd. 1,800,000
2026-05-13 13G WLII / Willow Lane Acquisition Corp. II 1,000,000
2026-05-13 13G TRGS / TRG Latin America Acquisitions Corp. 1,800,000
2026-05-13 13G SUMA / SUMA Acquisition Corporation 1,350,000
2026-05-13 13G SVIV / Spring Valley Acquisition Corp. IV 1,800,000
2026-05-13 13G TMTSU / Spartacus Acquisition Corp. II - Debt/Equity Composite Units 1,800,000
2026-05-13 13G SAAQ / Space Asset Acquisition Corp. 1,800,000
2026-05-13 13G SORN / Soren Acquisition Corp. 1,980,000
2026-05-13 13G QADRU / QDRO Acquisition Corp. - Debt/Equity Composite Units 1,500,000
2026-05-13 13G 2,767,441
2026-05-13 13G PALO / Paloma Acquisition Corp I 1,350,000
2026-05-13 13G IRD / Opus Genetics, Inc. 6,029,775
2026-05-13 13G OIM / OneIM Acquisition Corp. 2,250,000
2026-05-13 13G MUZE / Muzero Acquisition Corp 1,575,000
2026-05-13 13G MLAA / Mountain Lake Acquisition Corp. II 2,100,000
2026-05-13 13G MNRO / Monro, Inc. 1,500,000 1,548,270
2026-05-13 13G MTAL / Metals Acquisition Corp. II 1,800,000
2026-05-13 13G MEVO / M Evo Global Acquisition Corp II 2,430,000
2026-05-13 13G LEGO / Legato Merger Corp. IV 1,800,000
2026-05-13 13G KRAQ / KRAKacquisition Corp. 2,475,000
2026-05-13 13G KPTI / Karyopharm Therapeutics Inc. 436,736 1,821,736
2026-05-13 13G/A WVE / Wave Life Sciences Ltd. 9,786,061 1,000,000
2026-05-13 13G IRAB / Iris Acquisition Corp II 1,350,000
2026-05-13 13G IEAG / Infinite Eagle Acquisition Corp. 2,250,000
2026-05-13 13G IPFXU / Inflection Point Acquisition Corp. VI - Debt/Equity Composite Units 1,500,000
2026-05-13 13G/A TERN / Terns Pharmaceuticals, Inc. 5,550,000 2,124,817
2026-05-13 13G/A TNGX / Tango Therapeutics, Inc. 10,607,924 12,809,485
2026-05-13 13G HCIC / Hennessy Capital Investment Corp. VIII 1,890,000
2026-05-13 13G FVAV / Fortress Value Acquisition Corp. V 2,250,000
2026-05-13 13G/A RLMD / Relmada Therapeutics, Inc. 4,270,000 4,763,158
2026-05-13 13G/A SDRL / Seadrill Limited 3,138,286 2,463,436
2026-05-13 13G/A NPB / Northpointe Bancshares, Inc. 1,794,104 2,601,503
2026-05-13 13G FBRX / Forte Biosciences, Inc. 950,000
2026-05-13 13G FGII / FG Imperii Acquisition Corp. 1,800,000
2026-05-13 13G/A NBR / Nabors Industries Ltd. 1,260,000 740,000
2026-05-13 13G CMII / Columbus Circle Capital Corp II 1,800,000
2026-05-13 13G/A MNPR / Monopar Therapeutics Inc. 599,195 424,195
2026-05-13 13G CAQ / Cambridge Acquisition Corp. 1,800,000
2026-05-13 13G/A MIST / Milestone Pharmaceuticals Inc. 8,659,064 8,000,000
2026-05-13 13G BWIV.U / Blue Water Acquisition Corp. IV - Debt/Equity Composite Units 1,125,000
2026-05-13 13G/A MGTX / MeiraGTx Holdings plc 4,184,578 4,000,000
2026-05-13 13G BBCQ / Bleichroeder Acquisition Corp. II 2,250,000
2026-05-13 13G/A MCB / Metropolitan Bank Holding Corp. 559,479 584,633
2026-05-13 13G ACAA / Averin Capital Acquisition Corp. 2,250,000
2026-05-13 13G ATRA / Atara Biotherapeutics, Inc. 700,000
2026-05-13 13G/A INO / Inovio Pharmaceuticals, Inc. 5,517,650 4,233,529
2026-05-13 13G AACI / Armada Acquisition Corp. III 2,025,000
2026-05-13 13G/A HRTX / Heron Therapeutics, Inc. 8,850,000 0
2026-05-13 13G/A EYPT / EyePoint, Inc. 4,700,000 3,300,000
2026-05-13 13G ARCI / Archimedes Tech SPAC Partners III Co. 1,800,000
2026-05-13 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 14,614,449 22,272,884
2026-05-13 13G ALOV / Aldabra 4 Liquidity Opportunity Vehicle, Inc. 1,750,000
2026-05-13 13G/A CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 10,035,000 8,925,010
2026-05-13 13G AACO / Abony Acquisition Corp. I 1,800,000
2026-05-13 13G/A ADGM / Adagio Medical Holdings, Inc. 1,058,501 1,258,501
2026-02-12 13G VHCPU / Vine Hill Capital Investment Corp. II - Debt/Equity Composite Units 1,575,000
2026-02-12 13G SBXE / SilverBox Corp V 1,750,000
2026-02-12 13G TERN / Terns Pharmaceuticals, Inc. 5,550,000
2026-02-12 13G/A PRAX / Praxis Precision Medicines, Inc. 1,305,175 965,313
2026-02-12 13G TWLV / Twelve Seas Investment Company III 1,350,000
2026-02-12 13G RLMD / Relmada Therapeutics, Inc. 4,270,000
2026-02-12 13G SAC / Safeguard Acquisition Corp. 1,800,000
2026-02-12 13G TNGX / Tango Therapeutics, Inc. 2,511,000 10,607,924
2026-02-12 13G DSACU / Daedalus Special Acquisition Corp. - Debt/Equity Composite Units 1,800,000
2026-02-12 13G TRAW / Traws Pharma, Inc. 330,000 730,000
2026-02-12 13G/A SLDB / Solid Biosciences Inc. 4,000,000 1,400,000
2026-02-12 13G/A AMLX / Amylyx Pharmaceuticals, Inc. 6,816,828 2,777,055
2026-02-12 13G CCXIU / Churchill Capital Corp XI - Debt/Equity Composite Units 2,700,000
2026-02-12 13G/A ABEO / Abeona Therapeutics Inc. 5,352,996 0
2026-02-12 13G/A MNRO / Monro, Inc. 2,222,000 1,500,000
2026-02-12 13G/A EYPT / EyePoint, Inc. 5,559,782 4,700,000
2026-02-12 13G/A WVE / Wave Life Sciences Ltd. 15,016,500 9,786,061
2026-02-12 13G CRAN / Crane Harbor Acquisition Corp. II 2,700,000
2026-02-12 13G NBR / Nabors Industries Ltd. 1,260,000
2026-02-12 13G MCB / Metropolitan Bank Holding Corp. 559,479
2026-02-12 13G LFACU / Leapfrog Acquisition Corporation - Debt/Equity Composite Units 1,125,000
2026-02-12 13G LPCVU / Launchpad Cadenza Acquisition Corp I - Debt/Equity Composite Units 1,250,000
2026-02-12 13G VACI / Viking Acquisition Corp. I 1,800,000
2026-02-12 13G HCACU / Hall Chadwick Acquisition Corp. - Debt/Equity Composite Units 1,620,000
2026-02-12 13G TDWD / Tailwind 2.0 Acquisition Corp. 1,350,000
2026-02-12 13G/A KPTI / Karyopharm Therapeutics Inc. 6,551,055 436,736
2026-02-12 13G DYOR / Insight Digital Partners II 1,350,000
2026-02-12 13G GPACU / General Purpose Acquisition Corp. - Debt/Equity Composite Units 1,800,000
2026-02-12 13G APXT / Apex Treasury Corporation 2,250,000
2026-02-12 13G DNMX / Dynamix Corporation III 1,575,000
2026-02-12 13G KBONU / Karbon Capital Partners Corp. - Debt/Equity Composite Units 2,700,000
2026-02-12 13G NERV / Minerva Neurosciences, Inc. 2,838,000
2026-02-12 13G EVOX / Evolution Global Acquisition Corp 1,890,000
2026-02-12 13G AEAQU / Activate Energy Acquisition Corp. - Debt/Equity Composite Units 1,800,000
2026-02-12 13G KTTA / Pasithea Therapeutics Corp. 2,329,749
2026-02-12 13G BCSS / Bain Capital GSS Investment Corp. 3,000,000
2026-02-12 13G ADACU / American Drive Acquisition Company - Debt/Equity Composite Units 1,250,000
2026-02-12 13G IGACU / Invest Green Acquisition Corporation - Debt/Equity Composite Units 1,350,000
2026-02-12 13G LZM / Lifezone Metals Limited 5,075,122
2025-11-13 13G IBIO / iBio, Inc. 2,181,422
2025-11-13 13G INO / Inovio Pharmaceuticals, Inc. 5,517,650
2025-11-13 13G/A STR / Sitio Royalties Corp. 6,263,396 0
2025-11-13 13G/A ETHM / Dynamix Corporation 1,350,000 125,000
2025-11-13 13G EQ / Equillium, Inc. 6,012,624
2025-11-13 13G MIST / Milestone Pharmaceuticals Inc. 8,659,064
2025-11-13 13G/A ABEO / Abeona Therapeutics Inc. 4,411,572 5,352,996
2025-11-13 13G/A SLDB / Solid Biosciences Inc. 6,729,484 4,000,000
2025-11-13 13G/A SLNO / Soleno Therapeutics, Inc. 3,575,964 1,401,576
2025-11-13 13G/A EYPT / EyePoint, Inc. 6,800,000 5,559,782
2025-11-13 13G/A TRAW / Traws Pharma, Inc. 330,000 330,000
2025-11-13 13G/A AMLX / Amylyx Pharmaceuticals, Inc. 8,800,000 6,816,828
2025-11-13 13G/A ACRS / Aclaris Therapeutics, Inc. 8,201,344 5,278,144
2025-11-13 13G/A CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 8,403,000 10,035,000
2025-11-13 13G/A MGTX / MeiraGTx Holdings plc 5,229,099 4,184,578
2025-11-13 13G/A FULC / Fulcrum Therapeutics, Inc. 4,589,000 2,432,000
2025-11-13 13G OTGAU / OTG Acquisition Corp. I - Debt/Equity Composite Units 1,800,000
2025-11-13 13G/A ADGM / Adagio Medical Holdings, Inc. 821,261 1,058,501
2025-11-13 13G/A BBOT / BridgeBio Oncology Therapeutics, Inc. 1,487,621
2025-11-13 13G LATAU / Galata Acquisition Corp. II - Debt/Equity Composite Units 1,350,000
2025-11-13 13G TLNC / Talon Capital Corp. 2,025,000
2025-11-13 13G/A ZVRA / Zevra Therapeutics, Inc. 3,650,000 2,225,000
2025-11-13 13G NPB / Northpointe Bancshares, Inc. 1,794,104
2025-11-13 13G HVMC / Highview Merger Corp. 1,800,000
2025-11-13 13G MNRO / Monro, Inc. 2,222,000
2025-11-13 13G DRUG / Bright Minds Biosciences Inc. 395,743
2025-11-13 13G/A TNGX / Tango Therapeutics, Inc. 5,905,349 2,511,000
2025-11-03 13G/A PRAX / Praxis Precision Medicines, Inc. 2,374,085 1,305,175
2025-10-31 13D/A ETNB / 89bio, Inc. 9,097,587 0
2025-10-03 13D ETNB / 89bio, Inc. 9,097,587
2025-09-02 13G/A PRAX / Praxis Precision Medicines, Inc. 1,974,585 2,374,085
2025-08-12 13G/A AMLX / Amylyx Pharmaceuticals, Inc. 5,697,605 8,800,000
2025-08-12 13G/A TCRX / TScan Therapeutics, Inc. 1,350,000
2025-08-12 13G/A EYPT / EyePoint, Inc. 5,750,000 6,800,000
2025-08-12 13G ADGM / Adagio Medical Holdings, Inc. 821,261
2025-08-12 13G DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 14,614,449
2025-08-12 13G TNGX / Tango Therapeutics, Inc. 5,905,349
2025-08-12 13G/A IMUX / Immunic, Inc. 1,398,600 10,479,337
2025-08-12 13G/A JANX / Janux Therapeutics, Inc. 3,061,750 2,525,000
2025-08-12 13G/A SLNO / Soleno Therapeutics, Inc. 4,392,696 3,575,964
2025-08-12 13G/A CABA / Cabaletta Bio, Inc. 3,634,475 9,002,580
2025-08-12 13G/A SDRL / Seadrill Limited 4,200,535 3,138,286
2025-08-12 13G/A WVE / Wave Life Sciences Ltd. 12,516,500 15,016,500
2025-08-12 13G/A ENSC / Ensysce Biosciences, Inc. 74,711 74,711
2025-08-12 13G/A PRQR / ProQR Therapeutics N.V. 8,102,098 6,601,938
2025-08-12 13G/A PRAX / Praxis Precision Medicines, Inc. 1,742,758 1,974,585
2025-08-12 13G/A ZEO / Zeo Energy Corp. 760,000 760,000
2025-08-12 13G/A INZY / Inozyme Pharma, Inc. 0
2025-08-12 13G/A CDTX / Cidara Therapeutics, Inc. 990,000 1,100,000
2025-08-12 13G/A FULC / Fulcrum Therapeutics, Inc. 3,000,000 4,589,000
2025-08-12 13G/A CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 6,954,000 8,403,000
2025-08-12 13G/A ALGS / Aligos Therapeutics, Inc. 325,000 210,000
2025-06-20 13D/A 50,912
2025-05-12 13G/A PRQR / ProQR Therapeutics N.V. 9,602,280 8,102,098
2025-05-12 13G/A ACRS / Aclaris Therapeutics, Inc. 9,627,304 8,201,344
2025-05-12 13G/A SDRL / Seadrill Limited 3,429,169 4,200,535
2025-05-12 13G/A SLNO / Soleno Therapeutics, Inc. 3,322,146 4,392,696
2025-05-12 13G/A WVE / Wave Life Sciences Ltd. 9,703,351 12,516,500
2025-05-12 13G AMLX / Amylyx Pharmaceuticals, Inc. 5,697,605
2025-05-12 13G PRAX / Praxis Precision Medicines, Inc. 854,083 1,742,758
2025-05-12 13G CDTX / Cidara Therapeutics, Inc. 990,000
2025-05-12 13G SLDB / Solid Biosciences Inc. 1,754,159 6,729,484
2025-05-12 13G CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 6,954,000
2025-05-12 13G ENSC / Ensysce Biosciences, Inc. 74,711
2025-05-12 13G/A AEVA / Aeva Technologies, Inc. 1,401,454
2025-05-12 13G TRAW / Traws Pharma, Inc. 330,000
2025-05-12 13G/A URGN / UroGen Pharma Ltd. 2,928,086 1,277,000
2025-05-12 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 8,503,780
2025-05-12 13G/A TARA / Protara Therapeutics, Inc. 2,250,000 0
2025-05-12 13G/A ABEO / Abeona Therapeutics Inc. 4,210,429 4,411,572
2025-05-12 13G/A LXEO / Lexeo Therapeutics, Inc. 2,209,615 237,953
2025-02-12 13G PRQR / ProQR Therapeutics N.V. 9,602,280
2025-02-12 13G MNPR / Monopar Therapeutics Inc. 599,195
2025-02-12 13G/A IMUX / Immunic, Inc. 5,594,406 1,398,600
2025-02-12 13G KPTI / Karyopharm Therapeutics Inc. 6,551,055
2025-02-12 13G/A ENGN / enGene Therapeutics Inc. 2,329,768 1,528,768
2025-02-12 13G/A LXEO / Lexeo Therapeutics, Inc. 2,597,736 2,209,615
2025-02-12 13G/A EYPT / EyePoint, Inc. 3,791,420 5,750,000
2025-02-12 13G ETHM / Dynamix Corporation 1,350,000
2025-02-12 13G/A URGN / UroGen Pharma Ltd. 3,735,741 2,928,086
2025-02-12 13G ZVRA / Zevra Therapeutics, Inc. 3,650,000
2025-02-12 13G/A ALGS / Aligos Therapeutics, Inc. 218,813 325,000
2025-02-12 13G ACRS / Aclaris Therapeutics, Inc. 9,627,304
2025-02-12 13G SDRL / Seadrill Limited 3,429,169
2025-02-12 13G FULC / Fulcrum Therapeutics, Inc. 3,000,000
2025-02-12 13G TARA / Protara Therapeutics, Inc. 2,250,000
2025-02-12 13G JANX / Janux Therapeutics, Inc. 3,061,750
2025-02-12 13G STR / Sitio Royalties Corp. 6,263,396
2024-11-19 13G ZEO / Zeo Energy Corp. 760,000
2024-11-12 13G/A MGTX / MeiraGTx Holdings plc 5,229,099
2024-11-12 13G/A CABA / Cabaletta Bio, Inc. 3,634,475
2024-11-12 13G/A RZLT / Rezolute, Inc. 2,842,163
2024-11-12 13G/A GHLD / Guild Holdings Company, LLC 597,110
2024-11-12 13G/A AMAL / Amalgamated Financial Corp. 716,262
2024-11-12 13G/A PWP / Perella Weinberg Partners 1,037,615
2024-11-12 13G/A HOWL / Werewolf Therapeutics, Inc. 2,000,594
2024-11-12 13G/A CRBP / Corbus Pharmaceuticals Holdings, Inc. 528,937
2024-11-12 13G/A SVRA / Savara Inc. 6,753,701
2024-11-12 13G/A ANNX / Annexon, Inc. 3,485,931
2024-11-12 13G/A SLDB / Solid Biosciences Inc. 1,754,159
2024-11-12 13G HRTX / Heron Therapeutics, Inc. 8,850,000
2024-11-12 13G/A AURA / Aura Biosciences, Inc. 4,881,125
2024-11-12 13G/A SLNO / Soleno Therapeutics, Inc. 3,322,146
2024-11-12 13G/A VINP / Vinci Compass Investments Ltd. 0
2024-11-12 13G/A EYPT / EyePoint, Inc. 5,156,299 3,791,420
2024-11-12 13G/A WVE / Wave Life Sciences Ltd. 9,703,351
2024-11-12 13G/A STRO / Sutro Biopharma, Inc. 2,250,132
2024-11-12 13G/A VERU / Veru Inc. 7,861,111
2024-11-12 13G/A NKTX / Nkarta, Inc. 3,600,000
2024-11-12 13G/A PRAX / Praxis Precision Medicines, Inc. 854,083
2024-11-12 13G/A VSTM / Verastem, Inc. 0
2024-11-12 13G ENGN / enGene Therapeutics Inc. 2,329,768
2024-11-12 13G URGN / UroGen Pharma Ltd. 3,735,741
2024-11-12 13G LXEO / Lexeo Therapeutics, Inc. 2,597,736
2024-11-12 13G/A KALV / KalVista Pharmaceuticals, Inc. 1,419,792
2024-11-12 13G ALGS / Aligos Therapeutics, Inc. 218,813
2024-11-12 13G/A MTEM / Molecular Templates, Inc. 0
2024-11-12 13G IMUX / Immunic, Inc. 5,594,406
2024-11-12 13G TENX / Tenax Therapeutics, Inc. 369,097
2024-11-04 13D GLYC / GlycoMimetics, Inc. 5,091,231
2024-10-22 13D/A ORKA / Oruka Therapeutics, Inc. 175,000
2024-06-03 13G/A ABEO / Abeona Therapeutics Inc. 4,210,429
2024-05-01 13G/A EYPT / EyePoint, Inc. 5,156,299 5,156,299
2024-04-30 13G EYPT / EyePoint, Inc. 5,156,299
2024-04-05 13D ABIO / ARCA biopharma, Inc. 1,200,000